Its dual-action mechanism targets additional metabolic pathways, potentially offering enhanced benefits for those with more challenging metabolic conditions
These studies demonstrate that there is none or very little GLP-1R expression in the renal vasculature and GLP-1-induced renal artery vasodilation leading to increases in renal blood flow and glomerular filtration rate is diminished in spontaneously hypertensive rats [56, 57]
While these medications are generally well-tolerated, GLP-1 safety for non-obese individuals has not been extensively studied
Linoleic acid, on the other hand, is only a cis fatty acid (fig
A growing body of literature shows that when GLP-1 receptor agonists are administered, there are decreased levels of pro-inflammatory cytokines that are normally seen in the pathogenesis of many inflammatory diseases
However, one key consideration for many prospective users is the cost associated with this treatment